FindTrial
Sign In

Clinical Response and Nursing Strategies of Hepatic Arterial Infusion Chemotherapy in the Treatment of Patients with Advanced Liver Cancer

Clinical Response and Nursing Strategies of Hepatic Arterial Infusion Chemotherapy in the Treatment of Patients with Advanced Liver Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126929
Enrollment
Unknown
Registered
2026-06-18
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Patients undergoing hepatic arterial infusion chemotherapy:None

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 70 years old (including 18 and 70 years old); 2. Histological or cytological diagnosis of liver cancer, or confirmed as metastatic liver cancer through comprehensive histological or imaging assessment; 3. Patients undergoing hepatic artery infusion chemotherapy.

Exclusion criteria

Exclusion criteria: 1. Does not meet the inclusion criteria; 2. Patients who have undergone other surgeries concurrently.

Design outcomes

Primary

MeasureTime frame
Adverse reaction;—

Countries

China

Contacts

Public ContactWang Yongmei

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

1625509251@qq.com+86 20 34070330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026